Fair Value Calculator Fair Value Calculator
EN DE

TIRUSTA (TIRUSTA) Fair Value & Analysis

IN · Market cap ₹1.3B

T TIRUSTA TIRUSTA · BSE
Price₹133.90
Fair Value₹134.71
Upside+0.6%
Quality46/100
Watch TIRUSTA for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹101.03 – ₹168.39

Fair value as of: Jul 6, 2026

From 23 valuation models · updated 2 days ago

Share price +4.6% over the past month.

Price vs Fair Value (12 months)

₹216.40 ₹120.35 Fair Value ₹134.71 Jul 2025 Jul 2026

12‑month range ₹120.35 – ₹216.40 · fair‑value band ₹101.03 – ₹168.39 · the ₹133.90 price screens below the ₹134.71 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

TIRUSTA (TIRUSTA) currently trades at ₹133.90, while our model-based Fair Value estimate is ₹134.71 — implying the stock looks roughly 0.6% undervalued today. We read business quality at 46/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, TIRUSTA generated revenue of ₹3.7B at a net margin of 1.8%. Revenue declined 11.1% year over year. It earns a return on equity of 10.1%. Net debt stands at ₹1.1B. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹101.03 (bear case) to ₹168.39 (bull case); at ₹133.90, the current price sits within that range. The share trades about 39% below its 52-week high and 16% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹3.7B
Revenue growth (YoY) -11.1%
Net margin 1.8%
Return on equity 10.1%
Free cash flow ₹356M FY2026
P/E ratio 19.9
More key figures
Operating margin 6.4%
EPS (TTM) ₹6.74
EPS growth (YoY) +58.4%
Net debt ₹1.1B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

TIRUSTA reported revenue of ₹3.6B in FY2026 versus ₹3.1B in FY2022, a compound +3.7%/yr. Reported net income was ₹64.6M in FY2026, compounding −6.0%/yr from FY2022.

Revenue +3.7%/yr
FY22 ₹3.1B
FY23 ₹3.6B
FY24 ₹3.0B
FY25 ₹3.9B
FY26 ₹3.6B
Net income −6.0%/yr
FY22 ₹82.6M
FY23 ₹65.7M
FY24 ₹21.9M
FY25 ₹75.3M
FY26 ₹64.6M

Is TIRUSTA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "TIRUSTA Fair Value". https://www.fairvalue-calculator.com/stock/TIRUSTA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is TIRUSTA (TIRUSTA) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹134.71 versus a price of ₹133.90 — about +1% (undervalued). Model-based estimate, not financial advice.
What is the fair value of TIRUSTA?
Our model-based fair value for TIRUSTA is ₹134.71 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹133.90.
What is the quality score of TIRUSTA?
TIRUSTA has a Quality Score of 46/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of TIRUSTA (TIRUSTA)?
TIRUSTA reported trailing-twelve-month revenue of about ₹3.7B (latest available figure, as of Jul 6, 2026).
What is the net profit margin of TIRUSTA?
The net profit margin of TIRUSTA is about 1.8%, meaning it keeps roughly 1.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.